Multi-Omics and Digital Biomarkers for Dynamic Cardiometabolic Risk Prediction
Cardiometabolic risk changes as metabolic state, vascular injury, behavior and treatment evolve. Multi-omics assays characterize the underlying molecular state, whereas wearable sensors and continuous glucose monitoring capture physiological responses during daily life. This review asks whether combining these measurem...